Molecular mechanisms of corona drug candidate Molnupiravir unraveled
The United States recently secured 1.7 million doses of a compound that could help to treat Covid-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Studies, including work by MBExC member Patrick Cramer at the MPI for Biophysical Chemistry and researchers at JMU Würzburg, showed why











